Zhengye Biotechnology Holding ZYBT
NASDAQ ZYBT
$1.52 -0.02 (-1.30%)
As of: Nov 11, 2026 · 3:58 PM EST

Zhengye Biotechnology Holding (ZYBT) Raw Materials (2023 - 2025)

Updated

Zhengye Biotechnology Holding (ZYBT) posted Raw Materials of $1.12 million for the quarter ended Dec 31, 2025, up 8.2% from $1.03 million a year earlier.

Analysis

Zhengye Biotechnology Holding (ZYBT) Raw Materials (2023 - 2025) Analysis & Trends

As of Dec 31, 2025, Zhengye Biotechnology Holding's Raw Materials came in at $1.14 million, up 11.4% from the prior year.

  • In prior years, Zhengye Biotechnology Holding's Raw Materials was $1.02 million in the year ended Dec 31, 2024 (-27.0%) and $1.4 million in the year ended Dec 31, 2023.
  • The figure for the quarter ended Dec 31, 2025 stands as the highest quarterly Raw Materials since the quarter ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Zhengye Biotechnology Holding 72.98 Mn 69.39 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.13 Mn
Dec 31, 2024 1.02 Mn
Dec 31, 2023 1.39 Mn
API Access

Zhengye Biotechnology Holding Raw Materials API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=raw-materials&ticker=ZYBT&period=max&api_key=YOUR_API_KEY